Company Information

Company Infant Bacterial Therapeutics AB
ibtherapeutics.com
Type:
SME
Country:
Sweden
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
09 May 2022
Letter of Commitment
Next Communication on Progress (COP) due on:
31 December 2023

Financial Information